Abstract:OBJECTIVE:This study investigated the association between abnormal matrix metalloproteinase-9 (MMP-9) expression and bladder cancer (BC) development.MATERIALS AND METHODS:In a retrospective analysis, this study used tissue samples derived from 92 patients pathologically diagnosed with BC (experimental group), who were hospitalized between September 2012 and June 2014 at the Urinary Surgery of Department of Urology, Lanzhou University Second Hospital. As controls (control group), 63 normal pericancerous bladder mucosal tissues (3 cm distant form edge of BC foci) with confirmed pathology were selected from the same time period. Immunohistochemistry was employed to detect MMP-9 protein expression in the tissues and enzyme-linked immunosorbent assay was performed to measure MMP-9 protein levels in tissue samples of patients and control subjects. Finally, a meta-analysis was conducted to understand the overall impact of MMP-9 on BC pathogenesis. STATA 12.0 software (Stata Corp, College Station, TX, USA) was used for all statistical analyses.RESULTS:The MMP-9 positive expression rate in tissue samples and MMP-9 levels were significantly greater in the experimental group compared to the control group (both P < 0.001). The frequency of MMP-9 positive status showed statistically significant differences between G1 (low-grade) and G3 (high-grade) (P < 0.001), between G2 and G3 (P < 0.05), and between G1/G2 and G3 (P = 0.001). Our meta-analysis findings provided further evidence that MMP-9 positive expression status and MMP-9 levels in the experimental group were significantly higher than the control group (positive expressions: Odds ratio [OR] = 18.59, 95% confidence interval [95% CI] = 11.63-29.71, P < 0.001; expression levels: Standard mean difference = 1.51, 95%CI = 0.63-2.39, P = 0.001). The positive expression status of MMP-9 was notably lower in G1/G2 compared to G3 (OR = 0.24, 95%CI = 0.15-0.36, P < 0.001).CONCLUSION:Our study demonstrated that both positive expression status in tumor tissue and expression levels of MMP-9 are significantly elevated in BC patients and correlate with disease progression. Thus, MMP-9 can serve as a biomarker to determine the degree of BC malignancy.

Expression of Upa and MMP-9 in Bladder Cancer and Its Relationship with Tumor Angiogenesis

Expression of Matrix Metalloproteinase-9 and Their Correlation with Tumor Invasion, Metastasis in Gastric Carcinoma

Detection of uPA and MVD in human colorectal carcinoma tissue

Expression of MMP-2, MMP-9 and CD147 and Their Relationships in Bladder Transitional Cell Carcinoma

Elevated Expression of Matrix Metalloproteinase-9 is Associated with Bladder Cancer Pathogenesis.

UPA Mrna and MMP-9 Mrna Expression and Their Correlation with Invasion and Metastasis and Prognosis of Gastric Carcinoma

Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer

Expression of matrix metalloproteinase 9 and vascular endothelial growth factor in gastric cancer and its correlation with prognosis

EXPRESSION AND SIGNIFICANCE OF MMP-2 AND U-PA IN STOMACH CANCER

Expressions of Cath-D and MMP-9 Associated with Recurrence Metastasis and Prognosis of Bladder Transitional Cell Carcinoma

The expression and significance of integrinβ1,VEGF,MMP-9 in bladder transitional cell cancer

Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients

Relationship between MMP-9 and angiogenesis in renal cell cacinoma

Expression of matrix metalloproteinase-9 and vascular endothelial growth factor in gastric cancer and its correlation with invasion and metastasis

Expression of MMP-2, MMP-9, VEGF and RECK Genes in Bladder Cancer and Its Clinical Significance

Expressions of VEGF-C and MMP-9 in colorectal cancer and their clinical relevance:a tissue microarray analysis

Tumor-associated macrophages infiltration,MVD and VEGF expression in patients with bladder cancer

Expression of Urokinase-Type Plasminogen Activator (upa) and Vascular Endothelial Growth Factor (VEGF) in Esophageal Cancer and Their Influence to Tumor Angiogenesis

Expression of Upa and Micro-Vessel Density Correlate with Invasion and Metastasis of Hypopharyngeal Squamous Cell Carcinoma

Expression of CUGBP1 and VEGF in Bladder Cancer and Their Clinical Significance

Expression of Vascular Endothelial Growth Factors and Thrombospondin-1 in Bladder Transitional Cell Carcinona